BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 16638372)

  • 1. Sjögren syndrome and systemic lupus erythematosus are distinct conditions.
    Scheinfeld N
    Dermatol Online J; 2006 Jan; 12(1):4. PubMed ID: 16638372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.
    Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM
    Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, serologic, and genetic profiles of patients with associated Sjögren's syndrome and systemic lupus erythematosus.
    Szanto A; Szodoray P; Kiss E; Kapitany A; Szegedi G; Zeher M
    Hum Immunol; 2006 Nov; 67(11):924-30. PubMed ID: 17145372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between anti-Ro (SS-A) antibody-positive Sjögren's syndrome and anti-Ro (SS-A) antibody-positive lupus erythematosus.
    Provost TT; Talal N; Harley JB; Reichlin M; Alexander E
    Arch Dermatol; 1988 Jan; 124(1):63-71. PubMed ID: 3257371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic lupus erythematosus with Sjögren syndrome compared to systemic lupus erythematosus alone: a meta-analysis.
    Yao Q; Altman RD; Wang X
    J Clin Rheumatol; 2012 Jan; 18(1):28-32. PubMed ID: 22157271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-alpha-fodrin antibodies in Sjögren's syndrome in children.
    Maeno N; Takei S; Imanaka H; Oda H; Yanagi K; Hayashi Y; Miyata K
    J Rheumatol; 2001 Apr; 28(4):860-4. PubMed ID: 11327263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatic secondary Sjögren's syndrome in patients with systemic lupus erythematosus (SLE). Relation to anti-SS-A and anti-SS-B autoantibodies.
    Jonsson H; Nived O; Sturfelt G; Norberg R
    Scand J Rheumatol Suppl; 1986; 61():166-9. PubMed ID: 3495873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Ro (SSA) and anti-La (SSB) antibodies in lupus erythematosus and in Sjögren's syndrome.
    Lee LA
    Arch Dermatol; 1988 Jan; 124(1):61-2. PubMed ID: 3257370
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibodies to Ro and La.
    Reichlin M
    Ann Med Interne (Paris); 1998 Feb; 149(1):34-41. PubMed ID: 11490515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
    Goules A; Tzioufas AG; Manousakis MN; Kirou KA; Crow MK; Routsias JG
    J Autoimmun; 2006 May; 26(3):165-71. PubMed ID: 16621447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA typing of maternal HLA in congenital complete heart block: comparison with systemic lupus erythematosus and primary Sjögren's syndrome.
    Colombo G; Brucato A; Coluccio E; Compasso S; Luzzana C; Franceschini F; Quinzanini M; Scorza R
    Arthritis Rheum; 1999 Aug; 42(8):1757-64. PubMed ID: 10446878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association of systemic lupus erythematosus and Sjögren's syndrome].
    Szántó A; Kiss E; Sas A; Szegedi G; Zeher M
    Orv Hetil; 2005 Dec; 146(50):2533-8. PubMed ID: 16440498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of activated terminal complement (C5b-9) in cerebrospinal fluid from patients with central nervous system involvement of primary Sjogren's syndrome or systemic lupus erythematosus.
    Sanders ME; Alexander EL; Koski CL; Frank MM; Joiner KA
    J Immunol; 1987 Apr; 138(7):2095-9. PubMed ID: 3559203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromyelitis optica and non organ-specific autoimmunity.
    Pittock SJ; Lennon VA; de Seze J; Vermersch P; Homburger HA; Wingerchuk DM; Lucchinetti CF; Zéphir H; Moder K; Weinshenker BG
    Arch Neurol; 2008 Jan; 65(1):78-83. PubMed ID: 18195142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary Sjogren's syndrome in systemic lupus erythematosus defines a distinct disease subset.
    Baer AN; Maynard JW; Shaikh F; Magder LS; Petri M
    J Rheumatol; 2010 Jun; 37(6):1143-9. PubMed ID: 20360189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcgamma receptor-dependent mechanism.
    Reefman E; Horst G; Nijk MT; Limburg PC; Kallenberg CG; Bijl M
    Arthritis Rheum; 2007 Oct; 56(10):3399-411. PubMed ID: 17907194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cells and the loss of immunologic tolerance in Sjögren's syndrome and systemic lupus erythematosus.
    Hoffman RW
    Arthritis Rheum; 2007 Oct; 56(10):3180-2. PubMed ID: 17907162
    [No Abstract]   [Full Text] [Related]  

  • 18. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
    Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ
    Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies to alpha-fodrin in primary Sjögren's syndrome and SLE detected by an in vitro transcription and translation assay.
    Nordmark G; Rorsman F; Rönnblom L; Cajander S; Taussig MJ; Kämpe O; Winqvist O
    Clin Exp Rheumatol; 2003; 21(1):49-56. PubMed ID: 12673889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation of anti-60000 SSA antibody and anti-52000 SSA antibody with systemic lupus erythematosus and Sjögren's syndrome].
    Zhang FC; Liu L; Xu D
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(1):7-10. PubMed ID: 17403303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.